The balancing act of biotherapy: Be The Match BioTherapies’ Abby Waters on agility and beyond

[Adobe Stock]

Professionals in the biotherapy world are engaged in a sort of balancing act, juggling the nuances of product development, complex science, leadership dynamics, and patient-centricity. In a recent interview, Abby Waters, Ph.D., senior manager of solution owners at Be The Match BioTherapies, opens up about her decade-long journey navigating these multifaceted challenges. From embracing agile methodologies to driving data-informed decisions, Waters shares insights on leading teams, prioritizing patients, and envisioning the future in this quickly evolving field.

In the interview — part of our Women in Pharma and Biotech series, Waters provided insights on an array of subjects, from adopting the IT-based agile framework to cell-and-gene therapy to the art of hiring and weighing hard and soft skills in the biotherapy domain. She also provided advice on approaching data-driven decisions, and offered per…

Read more
  • 0

How data-savvy are you in drug discovery?

[Artem/Adobe Stock]

Hey there, drug discovery professionals: Ever wondered where you stand in the grand scheme of drug discovery data-savviness? We’ve created a short quiz to help you get an idea. Drug discovery and development is an increasingly data-intensive field, underscoring the need for data science to be a core drug discovery discipline. The industry has taken notice, and is rewarding professionals who excel at integrating research strategies with data analytics and AI. While this assessment is all in good fun, after we get sufficient data, we’ll crunch the numbers, analyze the percentiles and report back with analysis of the collective results. Your participation not only gives you personal insight but also contributes to a broader understanding that we’ll share in our upcoming reports.

We value your privacy; please be assured that we are not collecting any personal information through…

Read more
  • 0